Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Immunogenicity and Safety of Various Investigational and Licensed Formulations of Hepatitis B Surface Antigen (HBsAg) Vaccines.

NCT00805389 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00805389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00805389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Immunogenicity and Safety of Various Investigational and Licensed Formulations of Hepatitis B Surface Antigen (HBsAg) Vaccines.
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
December 15, 2008
Completion date
July 14, 2011
Enrollment
713 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b